CAeditome Logo

Home

Download

Statistics

Landscape

Help

Contact
Center for Computational Systems Medicine
Soverview

1. Gene summary of enriched editing regions

Soverview

2. Tumor-specific enriched editing regions

Comparison of enriched editing regions between tumor and normal.

Correlation of enriched editing regions with tumor stages.

Associations of enriched editing regions with cancer survival.

Soverview

3. Enriched editing regions and immune related genes

Soverview

4. Enriched editing regions and immune related splicing

Soverview

5. Enriched editing regions and immune infiltration

Soverview

6. Enriched editing regions and immune gene sets

Correlation of enriched editing regions with epithelial-mesenchymal transition.

Correlations of enriched editing regions with hypoxic.

Associations of enriched editing regions with hallmark gene sets from MSigDB.

Soverview

7. Enriched editing regions and drugs

Correlations between enriched editing regions and drug sensitivity.

Enriched editing regions targeted by drugs from DrugBank database.

Editing gene: SORBS1 (ImmuneEditome ID:10580)

1. Gene summary of enriched editing regions for SORBS1

check button Gene summary
Gene informationGene symbol

SORBS1

Gene ID

10580

GeneSynonymsCAP|FLAF2|R85FL|SH3D5|SH3P12|SORB1
GeneCytomap

10q24.1

GeneTypeprotein-coding
GeneDescriptionsorbin and SH3 domain-containing protein 1|Fas-ligand associated factor 2|SH3 domain protein 5|c-Cbl associated protein|ponsin
GeneModificationdate20230521
UniprotIDQ9BX66;A0A3B3IRW8;A0A3B3IT56;S4R406;A0A3B3IRR9
PubMed ID

check buttonUCSC image.
all structure

check buttonLocations of each EERs.
EERENSTENSGGeneNameRegionRepeatdsRNA structure
chr10:95332523-95333709:-ENST00000277982.8ENSG00000095637.19SORBS1intronicL2c,LTR49,AluSz,AluSxchr10:95332523-95333709:-.alignment
chr10:95332523-95333709:-ENST00000306402.9ENSG00000095637.19SORBS1intronicL2c,LTR49,AluSz,AluSxchr10:95332523-95333709:-.alignment
chr10:95332523-95333709:-ENST00000354106.6ENSG00000095637.19SORBS1intronicL2c,LTR49,AluSz,AluSxchr10:95332523-95333709:-.alignment
chr10:95332523-95333709:-ENST00000361941.6ENSG00000095637.19SORBS1intronicL2c,LTR49,AluSz,AluSxchr10:95332523-95333709:-.alignment
chr10:95332523-95333709:-ENST00000371227.7ENSG00000095637.19SORBS1intronicL2c,LTR49,AluSz,AluSxchr10:95332523-95333709:-.alignment
chr10:95332523-95333709:-ENST00000371239.4ENSG00000095637.19SORBS1intronicL2c,LTR49,AluSz,AluSxchr10:95332523-95333709:-.alignment
chr10:95332523-95333709:-ENST00000371241.4ENSG00000095637.19SORBS1intronicL2c,LTR49,AluSz,AluSxchr10:95332523-95333709:-.alignment
chr10:95332523-95333709:-ENST00000371245.6ENSG00000095637.19SORBS1intronicL2c,LTR49,AluSz,AluSxchr10:95332523-95333709:-.alignment
chr10:95332523-95333709:-ENST00000371246.5ENSG00000095637.19SORBS1intronicL2c,LTR49,AluSz,AluSxchr10:95332523-95333709:-.alignment
chr10:95332523-95333709:-ENST00000371247.5ENSG00000095637.19SORBS1intronicL2c,LTR49,AluSz,AluSxchr10:95332523-95333709:-.alignment
chr10:95332523-95333709:-ENST00000371249.5ENSG00000095637.19SORBS1intronicL2c,LTR49,AluSz,AluSxchr10:95332523-95333709:-.alignment
chr10:95332523-95333709:-ENST00000607232.4ENSG00000095637.19SORBS1intronicL2c,LTR49,AluSz,AluSxchr10:95332523-95333709:-.alignment
chr10:95386384-95388233:-ENST00000277982.8ENSG00000095637.19SORBS1exonicAluSx1,MIRb,AluJr,AluSzchr10:95386384-95388233:-.alignment
chr10:95386384-95388233:-ENST00000371246.5ENSG00000095637.19SORBS1exonicAluSx1,MIRb,AluJr,AluSzchr10:95386384-95388233:-.alignment
chr10:95390701-95390922:-ENST00000465489.1ENSG00000095637.19SORBS1ncRNA_intronicAluSx1chr10:95390701-95390922:-.alignment
chr10:95390701-95390922:-ENST00000474353.5ENSG00000095637.19SORBS1ncRNA_intronicAluSx1chr10:95390701-95390922:-.alignment
chr10:95418097-95419054:-ENST00000474353.5ENSG00000095637.19SORBS1ncRNA_intronicAluJr,AluSz,AluSq2chr10:95418097-95419054:-.alignment
chr10:95429208-95429388:-ENST00000474353.5ENSG00000095637.19SORBS1ncRNA_intronicAluSzchr10:95429208-95429388:-.alignment
chr10:95510347-95511399:-ENST00000474353.5ENSG00000095637.19SORBS1ncRNA_intronicAluSx1,AluJr,FLAM_Achr10:95510347-95511399:-.alignment
chr10:95515274-95515461:-ENST00000474353.5ENSG00000095637.19SORBS1ncRNA_intronicNoRepeatchr10:95515274-95515461:-.alignment
chr10:95552948-95555016:-ENST00000474353.5ENSG00000095637.19SORBS1ncRNA_intronicAluJr4,AluJr,AluSz6,AluSq2,(AC)n,L2a,AluSx1,HAL1chr10:95552948-95555016:-.alignment


Top

2. Tumor-specific enriched editing regions for SORBS1


all structure

check buttonComparison of enriched editing regions between tumor and normal.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypePBoxplot


Top

check buttonCorrelation of enriched editing regions with tumor stages.
* AnovaP<0.05, Pearson P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes, Path: Pathological stage, Cli: Clinical stage.
* Only shows the most significant correlation result of EERs/EAGs with either pathological stage or clinical stage according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeStageTypeAnovaPPRBoxplot


Top

check button Associations of enriched editing regions with cancer survival.
* Pkm<0.05 and Pcox<0.05.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypeIDPkmPcox_continuousHR_continuousKMPlot

Top

3. Enriched editing regions and immune related genes for SORBS1


all structure

check button Enriched editing regions and immune related genes.
* First, the associations between enriched editing regions and genes were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the gene relationships with immune were tested by three analyses: whether the gene is an immune gene (InnateDB、Immport、Immunome、Immunogenetic Related Information Source (IRIS)), whether the gene is associated with immune infiltration and whether the gene is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of genes with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeGenebetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark

More results



Top

4. Enriched editing regions and immune related splicing for SORBS1


all structure

check button Enriched editing regions and immune related splicing.
* First, the associations between enriched editing regions and splicing events were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the splicing relationships with immune were tested by three analyses: whether the splicing event locates in an immune gene (InnateDB、Immport, Immunome and Immunogenetic Related Information Source (IRIS)), whether the splicing event is associated with immune infiltration and whether the splicing event is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of splicing events with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeSplicingTypeSplicingGeneSplicingChrSplicingPositionbetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark

More results



Top

5. Enriched editing regions and immune infiltration for SORBS1


all structure

check button Associations of enriched editing regions with immune infiltration.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the fraction of different immune cells according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeIDImmuneCellPRCorrelationPlot
chr10:95386384-95388233:-ESCAEERMonocytes3.9294e-030.5274image
chr10:95386384-95388233:-LGGEERT_cells_CD4_memory_activated3.2091e-02-0.1769image
ENSG00000095637.19,SORBS1LGGEAGT_cells_CD4_memory_activated3.0643e-02-0.1689image
ENSG00000095637.19,SORBS1SARCEAGNK_cells_resting1.6242e-050.7833image
chr10:95386384-95388233:-STADEERT_cells_CD4_memory_resting1.3254e-03-0.3550image
chr10:95552948-95555016:-STADEERDendritic_cells_resting5.5932e-030.5702image
ENSG00000095637.19,SORBS1STADEAGMacrophages_M11.0125e-020.2206image


Top

6. Enriched editing regions and immune gene sets for SORBS1


all structure

check button Correlation of enriched editing regions with epithelial-mesenchymal transition.
* First, the differences of enriched editing regions between Epi and Mes groups (defined by KS-test) were compared (P<0.05 and Informative number >=20).
* Second, the correlations between enriched editing regions and gene set score of HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly edited between Epi and Mes group.
ID_eventscancerTypeE2M_PBoxplotCorPCorRCorrelationPlot


Top

check button Correlations of enriched editing regions with hypoxic.
* First, there are four hypoxia scores used in the database. The first three hypoxic scores were calculated on three gene sets of Buffa, Ragnum and Winter based on one previous study (PMID: 32024819). One last hypoxia score was defined on HALLMARK_HYPOXIA by GSVA method.
* Second, the correlations enriched editing regions with the four hypoxic scores were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly correlated with all four hypoxia gene set scores. For more results, please go to download page.
ID_eventscancerTypeBuffa_P Buffa_R Ragnum_P Ragnum_R Winter_P Winter_R HALLMARK_P HALLMARK_R CorrelationPlot


Top

check button Associations of enriched editing regions with hallmark gene sets from MSigDB.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerHallmarkTypeTypePRCorrelationPlot
ENSG00000095637.19,SORBS1BRCAGSVA_HALLMARK_PEROXISOMEEAG2.8509e-040.6546image
ENSG00000095637.19,SORBS1ESCAGSVA_HALLMARK_MITOTIC_SPINDLEEAG1.1688e-020.3948image
chr10:95386384-95388233:-ESCAGSVA_HALLMARK_PEROXISOMEEER4.2694e-02-0.3856image
ENSG00000095637.19,SORBS1LGGGSVA_HALLMARK_DNA_REPAIREAG4.8801e-02-0.1541image
chr10:95386384-95388233:-LGGGSVA_HALLMARK_DNA_REPAIREER2.9695e-02-0.1794image
ENSG00000095637.19,SORBS1OVGSVA_HALLMARK_UNFOLDED_PROTEIN_RESPONSEEAG1.0648e-020.4833image
ENSG00000095637.19,SORBS1SARCGSVA_HALLMARK_MTORC1_SIGNALINGEAG1.8028e-030.6267image
chr10:95386384-95388233:-STADGSVA_HALLMARK_MYC_TARGETS_V2EER2.5746e-030.3346image
chr10:95552948-95555016:-STADGSVA_HALLMARK_TNFA_SIGNALING_VIA_NFKBEER3.6050e-030.5934image
chr10:95418097-95419054:-STADGSVA_HALLMARK_INTERFERON_GAMMA_RESPONSEEER1.7872e-030.3694image
chr10:95332523-95333709:-STADGSVA_HALLMARK_PROTEIN_SECRETIONEER5.5721e-030.5279image
ENSG00000095637.19,SORBS1STADGSVA_HALLMARK_UNFOLDED_PROTEIN_RESPONSEEAG1.8147e-030.2661image


Top

7. Enriched editing regions and drugs for SORBS1


all structure

check button Correlations between enriched editing regions and drug sensitivity.
* First, the drug sensitivity (IS50) was estimated on 84 drugs by pRRophetic package.
* Second, the correlations between editing enriched regions and drug sensitivity were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the IS50 scores of 84 drugs according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerDrugTypePRCorrelationPlot
ENSG00000095637.19,SORBS1BRCAABT.888EAG7.7703e-030.5100image
ENSG00000095637.19,SORBS1ESCAGemcitabineEAG3.1676e-02-0.3403image
chr10:95386384-95388233:-ESCAAMG.706EER2.7493e-05-0.7153image
ENSG00000095637.19,SORBS1LGGBMS.708163EAG2.8601e-02-0.1710image
chr10:95386384-95388233:-LGGA.443654EER2.7567e-020.1818image
ENSG00000095637.19,SORBS1SARCBleomycinEAG9.1416e-030.5422image
chr10:95386384-95388233:-STADAG.014699EER2.5409e-030.3351image
chr10:95418097-95419054:-STADBIBW2992EER6.4464e-030.3249image
chr10:95332523-95333709:-STADAZD7762EER8.9353e-030.5022image
ENSG00000095637.19,SORBS1STADABT.888EAG2.4774e-02-0.1932image


Top

check button EAGs targeted by drugs from DrugBank database.
* EAG: EER-associated genes.
EERENSTUniprotIDDrugBankIDDrugDrugType